Sonic HealthPlus Pty Ltd - Sonic HealthPlus

Site

Sonic HealthPlus

Accreditation No.

18789

Site No.

20912

Date of Accreditation

19 Feb 2013

Address

Level 28, QV1, St Georges Terrace
Perth, WA 6000
Australia

sonichealthplus.com.au

Contact

Ms Jana Lysina P: +61 (08) 92420800

Availability

Services available to external clients

Supervision

Not Applicable

Scope of Accreditation

Sonic HealthPlus

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 2 Specimen collection, storage, handling and dispatch Urine Colour; Temperature
Creatinine
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Adelaide CBD (SA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Alexandria (NSW)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Brisbane Airport (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Brisbane CBD (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Bunbury (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Canberra (ACT)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Canning Vale (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Cannon Hill (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Carole Park (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Client Sites

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at client sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Dandenong (VIC)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Darwin CBD (NT)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Gladstone (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Guildford (NSW)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Hay Street (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Hobart (TAS)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Joondalup (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Karratha (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Kewdale (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Launceston (TAS)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Laverton North (VIC)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Loganholme (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Mackay (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Malaga (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Mandurah (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Melbourne CBD (VIC)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Moranbah (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Mt Isa GP Super Clinic (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Naval Base (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Newcastle (NSW)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Oxley (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Parramatta (NSW)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Perth CBD (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Rockingham (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Southport (QLD)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Sydney CBD (NSW)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Tullamarine (VIC)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus West Perth (WA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Wingfield (SA)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites
Sonic HealthPlus Wollongong (NSW)

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.